Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Nat Cell Biol
The ability of Pilaralisib (XL147) to inhibit this endogenous phosphorylation of AKT
11a-pentamethyl-1-(prop-1-en-2-yl)-icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid
CAS Number: 2114339-57-8
PubMed PMID: 25449811
Miglustat Hydrochloride 240551 Nat Cell BiolMiglustat, also known as OGT 918 and NB DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages). Miglustat is used to treat adults with mild to moderate Type I Gaucher disease and it is the first treatment to be approved for patients
US$ 38.00
US$ 38.00
US$ 38.00
US$ 119.00
US$ 72.00
US$ 38.00
US$ 6795.00
US$ 23.53
US$ 290000.00
Sold : Login>>